What to expect at this week's meetings on Moderna, J&J boosters
On Thursday and Friday, the FDA's independent advisory panel is set to discuss and vote on whether to authorize Moderna and Johnson & Johnson boosters for people 18 and older. If approved, the FDA and CDC both still need to sign off. The earliest that could happen is Oct. 22.
An initial and nonbinding vote on the Moderna booster has been scheduled for around 4:45 p.m. ET Thursday. Moderna's own scientific summary posted on Tuesday argues for a booster shot with a half dose given six months after the second shot.
An initial and nonbinding vote on the J&J booster has been scheduled for around 3:15 p.m. ET. Friday. Johnson & Johnson’s summary posted Tuesday makes the argument for a second shot, same as the first dose, given roughly six months after the single-shot vaccine.
On Friday, the National Institutes of Health will also present data on whether it's safe and effective to mix-and-match booster doses.
-ABC News' Sony Salzman, Eric M. Strauss, Sasha Pezenik